Podcast
MSL Talk: Tom Caravela, Eddie Power
Perceived, Probe, Reflect-KOL Engagement Model
Summary
In this episode, Tom Caravela is joined by Cto delve into her innovative KOL engagement model. Amy shares her career journey and introduces her perceive, probe, and reflect approach. The discussion covers the importance of pre-call planning, researching KOLs, and adapting to various personality types. Amy provides insights into effective probing techniques, setting up future engagements, and follow-up strategies. The conversation also addresses common mistakes made by MSLs and offers advice for overcoming challenges. The episode concludes with thoughts on the future of the MSL role and a reminder for listeners to subscribe and leave reviews.
My guest today is Amy Patel, Executive Medical Scientific Liaison, with Takeda Pharmaceuticals and she shares her KOL Engagement Model…Perceived, Probe, Reflect
Amy discusses…
👉 How she came up with “Perceived, Probe, Reflect”
👉 The importance of pre-calling plans for MSLs
👉 How MSLs should conduct research on their KOLs
👉 Her advice for MSLs on probing
👉 What MSLs need to take out of KOL meetings
👉 Recommendations for follow-ups
👉 Common mistakes with KOL engagement
KOL engagement model, MSL role evolution, pre-call planning strategies, effective probing techniques, common MSL mistakes
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Eddie Power
Podcast
MSL Talk: Tom Caravela, Sarah Snyder
The MSL - 4 Years, 200 Episodes…What’s new, What’s not
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO